The Covid-19 Plasma Boom Is Over. What Did We Learn From It?

The New York Times – Business:

The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.

Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.